知名学者引用


        除了所发表论文的被引用频次、期刊质量能够彰显学者的学术影响力以外,被知名学者引用也是一项学术评价的重要指标。
        当前同舟云学术认定的知名学者包括:诺贝尔奖、菲尔兹奖、图灵奖等奖项获得者,多个国家的院士,同舟云学术“2023全球学者学术影响力排行版”入榜的前10万学者等。

王沛 复旦大学上海医学院被知名学者引用:89人次(黄金会员以上可以申请导出本人论文被全部知名学者引用的数据)

1. 陈君石 中国 中国疾病预防控制中心 中国工程院院士 Cost-Effectiveness of Salt Substitution and Antihypertensive Drug Treatment in Chinese Prehypertensi..

2. 黄天荫 新加坡 National University Singapore 2020美国医学院院士 Development and Validation of a Preference-Based Glaucoma Utility Instrument Using Discrete Choice E..

3. 梁卓伟 中国 香港大学 2018美国医学院院士 Health State Utility Values for Type 2 Diabetes and Related Complications in East and Southeast Asia..

4. 邬堂春 中国 华中科技大学 2021中国工程院院士 Cost-Effectiveness of Drug Treatment for Chinese Patients With Stage I Hypertension According to the..

5. Smith, Lee 英国 Anglia Ruskin University Multimorbidity clusters and their contribution to well-being among the oldest old: Results based on ..

6. Karl,Peltzer 中国 台湾亚洲大学 Multimorbidity clusters and their contribution to well-being among the oldest old: Results based on ..

7. Koenig, Hans-Helmut 德国 University Medical Center Hamburg-Eppendorf Multimorbidity clusters and their contribution to well-being among the oldest old: Results based on ..

8. Nicola,Veronese 意大利 University of PALERMO Multimorbidity clusters and their contribution to well-being among the oldest old: Results based on ..

9. Valderas, Jose M. 新加坡 National University Health System The EORTC QLU-C10D distinguished better between cancer patients and the general population than PROP..

10. Eriksson, Johan G. 新加坡 NUS Yong Loo Lin School of Medicine Postpartum Screening for Type 2 Diabetes in Women With a History of Gestational Diabetes Mellitus: A..

11. Andrew,Bottomley 比利时 EORTC Data Center The EORTC QLU-C10D is a valid cancer-specific preference-based measure for cost-utility and health t..

12. Madeleine T,King 澳大利亚 University of Sydney The EORTC QLU-C10D is a valid cancer-specific preference-based measure for cost-utility and health t..

13. Irma M,Verdonck-de Leeuw 荷兰 Vrije Universiteit Amsterdam The EORTC QLU-C10D is a valid cancer-specific preference-based measure for cost-utility and health t..

14. Peter D,Siersema 荷兰 Radboud University Nijmegen The EORTC QLU-C10D is a valid cancer-specific preference-based measure for cost-utility and health t..

15. Madeleine T,King 澳大利亚 University of Sydney Chinese utility weights for the EORTC cancer-specific utility instrument QLU-C10D

16. 陈铮鸣 英国 University of Oxford Cost-Effectiveness of Salt Substitution and Antihypertensive Drug Treatment in Chinese Prehypertensi..

17. 李立明 中国 北京大学 教授、博士生导师 Cost-Effectiveness of Salt Substitution and Antihypertensive Drug Treatment in Chinese Prehypertensi..

18. Madeleine T,King 澳大利亚 University of Sydney Valuing quality of life for economic evaluations in cancer: navigating multiple methods

19. Bölte, Sven 瑞典 Karolinska Institutet Feasibility and cross-cultural validation of an adapted social skills group training programme (KONT..

20. Marcus Eng Hock,Ong 新加坡 Singapore General Hospital Asthma prescribing trends, inhaler adherence and outcomes: a Real-World Data analysis of a multi-eth..

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3